Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$859M |
| 2 |
Progressive
PGR
|
$429M |
| 3 |
Netflix
NFLX
|
$368M |
| 4 |
Danaher
DHR
|
$364M |
| 5 |
Adobe
ADBE
|
$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$710M |
| 2 |
Microsoft
MSFT
|
$619M |
| 3 |
NVIDIA
NVDA
|
$447M |
| 4 |
Eli Lilly
LLY
|
$391M |
| 5 |
AbbVie
ABBV
|
$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Artivion
AORT
$2.05B
| $297K | ﹤0.01% |
17,269
-16
| -0.1% | -$275 |
|
2252
Informatica
INFA
$7.55B
| $296K | ﹤0.01% |
16,013
-65
| -0.4% | -$1.2K |
|
2253
Manitowoc
MTW
$359M
| $296K | ﹤0.01% |
15,747
-19
| -0.1% | -$358 |
|
|
INBX
2254
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $295K | ﹤0.01% |
11,360
-31
| -0.3% | -$805 |
|
2255
Southern Missouri Bancorp
SMBC
$648M
| $293K | ﹤0.01% |
7,626
-765
| -9% | -$29.4K |
|
2256
Smith & Wesson
SWBI
$388M
| $293K | ﹤0.01% |
22,457
-25
| -0.1% | -$326 |
|
2257
RCI Hospitality Holdings
RICK
$315M
| $292K | ﹤0.01% |
3,851
-5
| -0.1% | -$379 |
|
2258
Steelcase
SCS
$1.97B
| $292K | ﹤0.01% |
37,911
-83
| -0.2% | -$640 |
|
2259
Arcturus Therapeutics
ARCT
$485M
| $290K | ﹤0.01% |
10,107
-13
| -0.1% | -$373 |
|
2260
Aecom
ACM
$16.8B
| $290K | ﹤0.01% |
3,421
-85,243
| -96% | -$7.22M |
|
2261
QCR Holdings
QCRH
$1.33B
| $290K | ﹤0.01% |
7,060
-1,934
| -22% | -$79.3K |
|
2262
Avidity Biosciences
RNA
$6.48B
| $289K | ﹤0.01% |
26,120
-36
| -0.1% | -$399 |
|
2263
SunCoke Energy
SXC
$667M
| $289K | ﹤0.01% |
36,771
-44
| -0.1% | -$346 |
|
2264
Altice USA
ATUS
$1.05B
| $289K | ﹤0.01% |
95,507
-175
| -0.2% | -$529 |
|
|
CHS
2265
DELISTED
Chicos FAS, Inc.
CHS
| $289K | ﹤0.01% |
53,929
-68
| -0.1% | -$364 |
|
2266
Adaptive Biotechnologies
ADPT
$1.96B
| $287K | ﹤0.01% |
42,778
-2
| -0% | -$13 |
|
|
VERV
2267
DELISTED
Verve Therapeutics
VERV
| $286K | ﹤0.01% |
15,255
-31
| -0.2% | -$581 |
|
2268
Ambac
AMBC
$422M
| $285K | ﹤0.01% |
20,053
-23
| -0.1% | -$327 |
|
2269
Blue Bird Corp
BLBD
$1.87B
| $285K | ﹤0.01% |
12,720
+12
| +0.1% | +$269 |
|
2270
Transcat
TRNS
$729M
| $285K | ﹤0.01% |
3,339
-4
| -0.1% | -$342 |
|
|
EBIX
2271
DELISTED
Ebix Inc
EBIX
| $285K | ﹤0.01% |
11,326
-14
| -0.1% | -$353 |
|
2272
Peoples Bancorp
PEBO
$1.1B
| $285K | ﹤0.01% |
10,745
+23
| +0.2% | +$610 |
|
|
UHT
2273
Universal Health Realty Income Trust
UHT
$574M
| $285K | ﹤0.01% |
5,998
-7
| -0.1% | -$332 |
|
2274
ProPetro Holding
PUMP
$496M
| $284K | ﹤0.01% |
34,402
-141
| -0.4% | -$1.16K |
|
2275
America's Car Mart
CRMT
$299M
| $283K | ﹤0.01% |
2,839
-875
| -24% | -$87.2K |
|